Unique ID issued by UMIN | UMIN000006993 |
---|---|
Receipt number | R000008251 |
Scientific Title | a clinical case controled trial for the intraocular tamponade in the vitrectomy for rhegmatogenous retinal detachment(RRD). |
Date of disclosure of the study information | 2012/01/01 |
Last modified on | 2011/12/30 20:11:53 |
a clinical case controled trial for the intraocular tamponade in the vitrectomy for rhegmatogenous retinal detachment(RRD).
RRD tamponade study
a clinical case controled trial for the intraocular tamponade in the vitrectomy for rhegmatogenous retinal detachment(RRD).
RRD tamponade study
Japan |
Rhegmatogenous retinal detachment
Ophthalmology |
Others
NO
Sulfer hexafluoride(SF6) is commonly used for the treatment of the rhegmatogenous retinal detachment(RRD).
In order to make face down position of post operative 7-10 days. After vitrectomy using other kinds of taamponade materials. We hypothesize to use room air instead of SF6 would be able to make face down term shorter than that of SF6.
Efficacy
Confirmatory
Pragmatic
we try to compare the improvement of the retio of reattachment and BCVA after vitrectomy at the point of 1.3.6.12 months postoperatively.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
Pseudo-randomization
2
Treatment
Maneuver |
We replace vitreous with air at the end of surgery. The air tamponade will disappear applex 7 days.
We replace vitreous with SF6 at the end of surgery. The air tamponade will disappear applex 14 days.
20 | years-old | <= |
Not applicable |
Male and Female
The RRD patients who consulted this hospital and meet following criterion.
.A clinical record at the time of study entry contains no definiency for essential points.
.20 yearsold or older.
.The affected eye caan be evaluated of the retinal tear at the upper of retina and the RRD is not old RRD.
.The affected eye shuld have no other clinically significant abnormality which may cause loss of vision.
.The affected eye does noy have the record of votreous surgery.
.The eye length oh affected eye is not 26mm or over 26mm.
.When the patient does not hope for entry.
.In the case when there is a unsuspected worsening of the disease or advance event which the patient should exist this study.
50
1st name | |
Middle name | |
Last name | Toshimitsu Ishiguro |
Kansai medical university
Hirakata hospital
2-3-1,shinmachi,hirakata city,Osaka
0728040101
1st name | |
Middle name | |
Last name | Toshimitsu Ishiguro |
Kansai medical university
Hirakata hospital
2-3-1,shinmachi,hirakata city,Osaka
0728040101
Department of ophthalmology,Kansai medical university
none
Other
NO
2012 | Year | 01 | Month | 01 | Day |
Unpublished
Preinitiation
2011 | Year | 10 | Month | 20 | Day |
2012 | Year | 01 | Month | 01 | Day |
2011 | Year | 12 | Month | 30 | Day |
2011 | Year | 12 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008251
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |